BioSpace News Archive

Quanta Therapeutics, a privately-held biopharmaceutical company pioneering targeted therapies to treat RAS-driven cancers, announced data from a late-breaking presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics being held October 11-15, 2023, in Boston, Massachusetts.

Neurolief, a global medical device company that is delivering life-changing neurotechnology innovations, today announced the appointment of Steve Beller, an experienced senior commercial leader in neurotechnology, as Chief Commercial Officer (CCO).

Insight Therapeutics, LLC, a contract research organization focused on improving the care of older adults, announced a major expansion in its research capabilities.

Biocare Medical, a trusted provider of immunohistochemistry (IHC) instrumentation, antibodies and molecular probe for tumor diagnostics, is proud to announce a strategic partnership as the preferred vendor for histology and IHC at EmeritusDX, a world-class CAP accredited and CLIA certified laboratory.

Covalon Technologies Ltd., a leader in advanced medical technologies, announced its participation in the American Nurses Credentialing Center Magnet Conference.

In October 2022, we launched questhealth.com to better deliver actionable diagnostic insights directly to health-minded consumers without first requiring a doctor’s visit.

Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the third quarter of 2023 after the market close on November 8th, 2023.

Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”) today announced that it will present new preclinical data demonstrating the potential of epigenomic controllers for the treatment of inflammatory and fibrotic liver diseases at the American Association for the Study of Liver Diseases’ (AASLD) The Liver Meeting® 2023, taking place in Boston, Massachusetts, November 10 – 14.

Illumina, Inc. posted a stewardship-focused presentation for investors on the Events & Presentations section of its investor relations website, investor.illumina.com, on Wednesday, October 11, 2023.

Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), announced today that it will report fourth quarter and fiscal 2023 financial results after the market close on Wednesday, October 25, 2023.